Anticancer nanoparticulate polymer-drug conjugate
| dc.contributor.author | Feng, Quanyou | en |
| dc.contributor.author | Tong, Rong | en |
| dc.date.accessioned | 2020-11-09T17:07:42Z | en |
| dc.date.available | 2020-11-09T17:07:42Z | en |
| dc.date.issued | 2016-08-26 | en |
| dc.description.abstract | We review recent progress in polymer-drug conjugate for cancer nanomedicine. Polymer-drug conjugates, including the nanoparticle prepared from these conjugates, are designed to release drug in tumor tissues or cells in order to improve drugs’ therapeutic efficacy. We summarize general design principles for the polymer-drug conjugate, including the synthetic strategies, the design of the chemical linkers between the drug and polymer in the conjugate, and the in vivo drug delivery barriers for polymer-drug conjugates. Several new strategies, such as the synthesis of polymerdrug conjugates and supramolecular-drug conjugates, the use of stimulus-responsive delivery, and triggering the change of the nanoparticle physiochemical properties to over delivery barriers, are also highlighted. | en |
| dc.format.mimetype | application/pdf | en |
| dc.identifier.doi | https://doi.org/10.1002/btm2.10033 | en |
| dc.identifier.uri | http://hdl.handle.net/10919/100809 | en |
| dc.identifier.volume | 1 | en |
| dc.language.iso | en | en |
| dc.publisher | Wiley | en |
| dc.rights | Creative Commons Attribution 4.0 International | en |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | en |
| dc.subject | drug delivery | en |
| dc.subject | nanomedicine | en |
| dc.subject | nanoparticle | en |
| dc.subject | polymer-drug conjugate | en |
| dc.subject | stimuli-responsive | en |
| dc.title | Anticancer nanoparticulate polymer-drug conjugate | en |
| dc.title.serial | Bioengineering & Translational Medicine | en |
| dc.type | Article - Refereed | en |
| dc.type.dcmitype | Text | en |